{"id":228583,"date":"2026-01-08T17:06:45","date_gmt":"2026-01-08T23:06:45","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/01\/dr-christie-m-ballantyne-dr-alexander-tal-oral-pcsk9-therapy-and-the-future-of-heart-disease"},"modified":"2026-01-08T17:06:45","modified_gmt":"2026-01-08T23:06:45","slug":"dr-christie-m-ballantyne-dr-alexander-tal-oral-pcsk9-therapy-and-the-future-of-heart-disease","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/01\/dr-christie-m-ballantyne-dr-alexander-tal-oral-pcsk9-therapy-and-the-future-of-heart-disease","title":{"rendered":"Dr. Christie M. Ballantyne &amp; Dr. Alexander Tal \u2014 Oral PCSK9 Therapy And The Future Of Heart Disease"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/ANPedCARbnI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Oral PCSK9 Therapy And The Future Of Heart Disease \u2014 Dr. Christie Ballantyne MD, Director, Center for Cardiometabolic Disease Prevention, Baylor College of Medicine &amp; Dr. Alexander Tal, MD.<\/p>\n<hr>\n<p>Dr. Christie M. Ballantyne, MD is a Cardiologist and is one of the nation\u2019s foremost experts on lipids, atherosclerosis and heart disease prevention. He holds many leadership positions at Baylor College of Medicine (<a href=\"https:\/\/www.bcm.edu\/people-search\/chr\">https:\/\/www.bcm.edu\/people-search\/chr<\/a>\u2026 including director of the Center for Cardiometabolic Disease Prevention, co-director of the Lipid Metabolism and Atherosclerosis Clinic, and chief of the Section of Cardiology.<\/p>\n<p>With over 1,000 publications in the area of atherosclerosis, lipids, and inflammation, Dr. Ballantyne\u2019s research on heart disease prevention has led him to become an established investigator for the American Heart Association and the recipient of continuous funding from the National Institutes of Health with a core focus on in basic research of leukocyte\u2013endothelial interactions, translational research in biomarkers, and clinical trials.<\/p>\n<p>Dr. Ballantyne\u2019s many accomplishments have included being elected as Fellow of the American Association for the Advancement of Science, the American Society of Clinical Investigation, and the Association of American Physicians. In 2012, he received the American College of Cardiology Distinguished Scientist Award (Basic Domain).<\/p>\n<p>In 2014 and 2015, Thomson Reuters recognized Dr. Ballantyne as one of \u201cThe World\u2019s Most Influential Scientific Minds.\u201d Clarivate Analytics, Web of Science, named Dr. Ballantyne as a \u201cHighly Cited Researcher\u201d 2017\u20132022 in the top 1% of researchers most cited.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2026\/01\/dr-christie-m-ballantyne-dr-alexander-tal-oral-pcsk9-therapy-and-the-future-of-heart-disease\">Continue reading \u201cDr. Christie M. Ballantyne &amp; Dr. Alexander Tal \u2014 Oral PCSK9 Therapy And The Future Of Heart Disease\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oral PCSK9 Therapy And The Future Of Heart Disease \u2014 Dr. Christie Ballantyne MD, Director, Center for Cardiometabolic Disease Prevention, Baylor College of Medicine &amp; Dr. Alexander Tal, MD. Dr. Christie M. Ballantyne, MD is a Cardiologist and is one of the nation\u2019s foremost experts on lipids, atherosclerosis and heart disease prevention. He holds many [\u2026]<\/p>\n","protected":false},"author":400,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,1495],"tags":[],"class_list":["post-228583","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228583","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/400"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=228583"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228583\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=228583"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=228583"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=228583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}